// App-Quantinova.ai

280 : Safety of Filgotinib in Patients with RA: Laboratory Analysis Results from a Long-Term Extension Study

Researchers

Presenter

  • Maya Buch

Principal Investigators

  • James Galloway

  • Ennio Giulio Favalli

  • Arnaud Constantin

  • Patrick Durez

  • Paul Van Hoek

  • Christopher Watson

  • Pieter-Jan Stiers

  • Vijay Rajendran

  • Katrien Van Beneden

  • Tsutomu Takeuchi

  • BERNARD COMBE

Medical Centers

  • University of Manchester and NIHR Manchester Biomedical Research Centre, Manchester, United Kingdom

  • Kings College London, London, United Kingdom

  • University of Milan, ASST Gaetano Pini-CTO Institute, Milano, Italy

  • Toulouse University Hospital, Universite Paul Sabatier, Toulouse, France

  • Rheumatology, Cliniques universitaires Saint-Luc – Université Catholique de Louvain – Institut de Recherche Expérimentale et Clinique (IREC)

  • Galapagos, Mechelen, Belgium

  • Galapagos Biotech Ltd, Cambridge, United Kingdom

  • Galapagos NV, Gent, Belgium

  • Keio University and Saitama Medical University, Tokyo, Japan

  • Montpellier Universitary Hospital, Montpellier, France

Locations

  • United Kingdom

  • Italy

  • France

  • Belgium

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • Filgotinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • NCT03025308

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved